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Introduction: Hypoxia is associated with increased capillary permeability. This study
tested whether acute hypobaric hypoxia involves degradation of the endothelial
glycocalyx.
Methods: We exposed 12 subjects to acute hypobaric hypoxia (equivalent to 4500m for
2–4 h) and measured venous blood concentrations of biomarkers reflecting endothelial
and glycocalyx degradation (catecholamines, syndecan-1, soluble CD40 ligand, protein
C, soluble thrombomodulin, tissue-type plasminogen activators, histone-complexed DNA
fragments, and nitrite/nitrate). Endothelial function was assessed by the hyperemic
response to brachial artery occlusion by peripheral arterial tonometry.
Results: Compared with normoxic baseline levels, hypoxia increased concentrations of
syndecan-1 from 22 (95% confidence interval: 17–27) to 25 (19–30) ng/ml (p < 0.02)
and protein C from 76 (70–83)% to 81 (74–88)% (p < 0.02). Nitrite/nitrate decreased
from 23 (18–27) µM at baseline to 19 (14–24) µM and 18 (14–21) µM in hypoxia
and recovery, respectively (p < 0.05). Other biomarkers remained unchanged. The
post-occlusion/pre-occlusion ratio (reactive hyperemia index, RHI) decreased from 1.80
(1.52–2.07) in normoxia to 1.62 (1.28–1.96) after 2–4 h of hypobaric hypoxia and thereafter
increased to 2.43 (1.99–2.86) during normoxic recovery (p < 0.01).
Conclusions: The increase in syndecan-1 and protein C suggests that acute hypobaric
hypoxia produces a minor degree of glycocalyx degradation and overall cellular damage.
After hypoxia RHI rebounded to higher than baseline levels suggesting improved
endothelial functionality.
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INTRODUCTION
Acute hypoxia rapidly activates endothelial cells leading to
increased vascular permeability and initiation of prothrombotic
and inflammatory reactions (Ten and Pinsky, 2002; Gonzalez and
Wood, 2010). Hypoxic exposure may also result in endothelium-
dependent vasoconstriction, both by release of endothelial-
derived substances including endothelins, superoxide anions and
thromboxane A2, and by a decrease in nitric oxide bioavailabil-
ity (Schneider et al., 2001; Ten and Pinsky, 2002; Bärtsch et al.,
2005; Gonzalez and Wood, 2010). In subjects susceptible to high
altitude pulmonary edema (HAPE), strong evidence exists to sug-
gest that impairment of systemic endothelial function is a main
cause of enhanced hypoxic pulmonary vasoconstriction in these
subjects (Busch et al., 2001; Swenson et al., 2002; Berger et al.,
2005).
The luminal side of the endothelium is lined by the glycocalyx
consisting of a 0.2–1µm thick negatively charged, antiadhesive
and anticoagulant carbohydrate-rich layer which protects the
endothelium and contributes to its barrier function (Pries et al.,
2000; Johansson et al., 2011). Degradation of the glycocalyx
results in local thrombin formation, fibrinolysis, and adhesion
of platelets and leucocytes (Vink et al., 2000; Nieuwdorp et al.,
2006; Chappell et al., 2010). In trauma patients and patients with
acute myocardial infarction, high levels of circulating syndecan-
1, a transmembrane endothelial proteoglycan and a marker of
endothelial glycocalyx degradation (Pries et al., 2000), is associ-
ated with inflammation, coagulopathy, and increased mortality
(Johansson et al., 2011; Ostrowski et al., 2013a,b). Acute expo-
sure to hypoxia may occur in high altitude and aviation activities
and also acute oxygen deprivation encompasses several clinical
modalities such as smoke intoxication, respiratory distress syn-
drome, pulmonary and cardiac thromboembolism, sepsis, and
trauma. In this study, we evaluated whether exposure to short-
term, acute hypobaric hypoxia is associated with degradation of
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the endothelial glycocalyx. The effect of short-term hypoxia per se
was studied in healthy subject by the use of a low-pressure cham-
ber. The response of endothelial cells to shear stress was assessed
by digital pulse amplitude tonometry (Faizi et al., 2009; Hamburg
and Benjamin, 2009; Hedetoft and Olsen, 2014).
MATERIALS AND METHODS
SUBJECTS AND EXPERIMENTAL PROTOCOL
Twelve healthy males aged 25 (20–29) years (mean and range),
height 181 (173–189) cm and body mass index 22 (18–26) kg/m2
entered the study after having given their written, informed con-
sent. The study was approved by the Regional Ethical Committee
of the Copenhagen Region, 2 Kongens Vaenge, DK-3400 Hillerød,
Denmark, E-mail: regionh@regionh.dk (J.No. H-4-2011-080).
All subjects were non-smokers living at sea level and free of
disease and medication. After an overnight fast, the subjects
arrived to the laboratory at 08.00 a.m. The subjects abstained
from heavy physical exercise and alcohol intake in the preceding
24 h. Drinking water was provided freely during the experiment.
The experiment was conducted inside a low-pressure cham-
ber with four subjects in each session. After insertion of an
intravenous catheter in a cubital vein, the subjects rested for
at least 1 h in a sitting position that was maintained through-
out the study period. Thereafter, baseline measurements by
digital pulse amplitude tonometry and blood samples were
obtained in normobaric normoxia (open chamber). The cham-
ber was then decompressed (over 15–20min) to a simulated
altitude af 4500m above sea level. This decompression pro-
duces a hypobaric hypoxia comparable to that obtained in
high altitude laboratories (Pikes Peak, Colarado, USA; Regina
Margherita Hut, Monte Rosa, Italy; and l’Observatoire Vallot,
Mont Blanc, France). In each session, measurements in the four
subjects, in succession one by one, were conducted within 2–
4 h in hypobaric hypoxia. Finally, measurements were repeated
in the recovery period 1–3 h after re-compression to ambi-
ent normoxic conditions. At the same time points heart rate
and arterial pressure were measured and arterial blood was
sampled for analysis of SaO2,PaCO2,PaO2, and pH, and con-
centrations of hemoglobin, glucose, and lactate by the use
of a Radiometer ABL 725 device (Radiometer Medical A/S,
Copenhagen, Denmark).
ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) MEASUREMENTS
Soluble biomarkers of sympathoadrenal activation, endothe-
lial cell and glycocalyx activation and damage, natural anti-
coagulation, fibrinolysis and platelet activation were measured
at baseline, and again at recovery by commercially available
immunoassays in plasma/serum according to the manufac-
tures recommendations. Adrenaline and noradrenaline (sym-
pathoadrenal activation) were measured in EDTA plasma by
a 2-CAT ELISA, Labor Diagnostica Nord GmbH & Co. KG,
Nordhorn, Germany. Lower limits of detection (LLD) were
10 pg/ml (normal reference <100 pg/ml) and 50 pg/ml (nor-
mal reference <600 pg/ml), respectively. Histone-complexed DNA
fragments (endothelial cell damage) in EDTA plasma were mea-
sured by a Cell Death Detection ELISAPLUS, Roche, Hvidovre,
Denmark (LLD not stated, relative quantification). Soluble
CD40 ligand (pro-inflammatory activation) was determined
by ELISA (sCD40L, R&D Systems Europe; LLD 4.2 pg/ml).
Soluble thrombomodulin (natural anticoagulation) and Protein
C (endothelial cell damage) were measured in citrate plasma
(sTM, Nordic Biosite, Copenhagen, Denmark, LLD 0.38 ng/ml;
and PC, Helena Laboratories, Beaumont, TX, US, LLD not
stated, relative quantification). Tissue-type plasminogen activa-
tors (fibrinolysis and platelet activation) were measured in
citrate plasma (tPA, ADI, detects sc-tPA, tc-tPA, and tPA/PAI-
1 complexes; LLD 1 ng/ml). Syndecan-1 (glycocalyx activa-
tion and damage) was determined in serum (Diaclone SAS,
Besancon, France; LLD 4.94 ng/ml). Samples for measurement
of nitrite/nitrate were spun through a 30-kD micropore fil-
ter (Nanosep 30k Omega, Pall Corp., Ann Arbor, Michigan)
prior to duplicate analysis with a commercially available NOx
detection kit based on the Griess reaction (cat. 780001,
Nitrite/Nitrate Colorimetric Assay Kit, Cayman Chemicals, Ann
Arbor, Michigan).
DIGITAL PULSE AMPLITUDE TONOMETRY
We used an EndoPAT 2000 device (Itamar Medical Ltd., Caesarea,
Israel) consisting of a fingertip plethysmograph (Faizi et al., 2009;
Hamburg and Benjamin, 2009; Hedetoft and Olsen, 2014). The
device includes two fingerprobes, each placed on a fingertip on
each hand. These are used for parallel measurements and are
connected to a computer. The probe consists of a rigid exter-
nal cap around an air-filled chamber with a sensor. When the
chamber is filled with air, a uniform pressure is provided which
prevents the veno-arteriolar vasoconstrictive reflex. The probe
detects changes in volume in relation to the arterial pulsation. A
cuff was placed on the arm in which the measurement was per-
formed. Measurements by the other probe served as a control.
Each measurement consisted of three phases: baseline, occlu-
sion and reactive hyperemia. For baseline measurements, the
probe was set to inflate to 10mmHg below diastolic pressure.
For occlusion, the test arm was occluded to suprasystolic pressure
for 5min (Faizi et al., 2009). The subsequent increase in blood
flow leads to a flow-mediated dilatation, manifesting as reactive
hyperemia, which was measured by the device as an increase
in the pulse-signal amplitude. The EndoPAT software calcu-
lates a post-occlusion/pre-occlusions-ratio, the reactive hyper-
emia index (RHI). An RHI ≤ 1.67 is described as being abnormal
by the manufacturer (http://www.itamar-medical.com/images/
EndoPATMultiFunctionUSA.pdf).
STATISTICAL ANALYSIS
Statistical analysis was performed using IBM SPSS Statistics 20
(IBM SPSS Statistics, Armonk, NY). Values during hypoxia and
in the post-hypoxic recovery period were compared with base-
line by the use of paired t-tests. Correlations between EndoPAT
RHI values and endothelial markers that had changed signifi-
cantly during the experiment, and between RHI and NOx values,
all at identical time points, were investigated by Pearson’s and
Spearman’s correlation as well as linear and logarithmic regres-
sion (by curve estimation). A level of P < 0.05 was considered
statistical significant. Results are presented as means with 95%
confidence intervals.
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RESULTS
Heart rate and mean arterial blood pressure remained unchanged
(Table 1). PaO2, PaCO2 and O2 saturation decreased during
hypoxia, whereas pH and lactate increased (Table 1); values were
restored to baseline levels during the ensuing period of normoxia
(recovery) with the exception of PaCO2 that remained lower than
baseline levels (Table 1). Also plasma hemoglobin concentration
at recovery was lower compared with baseline (Table 1). Venous
plasma concentrations of nitrite/nitrate decreased during hypoxia
compared with baseline, and remained at a similar level during
recovery (Table 1).
Syndecan-1 and protein C increased from the baseline lev-
els to the recovery levels (Table 2). Concentrations of adrenaline,
noradrenaline, thrombomodulin, tissue-type plasminogen acti-
vators, plasminogen activator inhibitor 1, soluble CD40 ligand,
and histone-complexed DNA fragments remained unchanged
(Table 2).
Table 1 | Effect of hypobaric hypoxia.
Baseline Hypoxia Recovery
Heart rate (min−1) 70 (62–77) 75 (69–81) 68 (62–74)
MABP (mm Hg) 90 (85–95) 83 (76–90) 84 (77–90)
pH 7.40 (7.39–7.41) 7.47 (7.46–7.49)* 7.42 (7.39–7.45)
PaO2 (mm Hg) 103 (99–107) 43 (39–46)* 102 (98–106)
PaCO2 (mm Hg) 40 (38–42) 32 (30–35)* 36 (34–37)*
SaO2 (%) 98 (98–98) 81 (77–85)* 99 (98–99)
Hgb (mM) 9.8 (9.1–10.4) 9.3 (9.0–9.6) 9.2 (8.8–9.5)*
Lactate (mM) 0.84 (0.65–1.02) 1.29 (1.05–1.53)* 0.90 (0.63–1.17)
NOx (µM) 22.7 (18.3–27.1) 19.2 (14.4–24.1) 17.8 (14.6–21.1)*
Data are presented as means with 95% confidence intervals. n = 12, exept for
NOx where n = 11 in hypoxia and recovery. MABP, mean arterial blood pressure;
PaO2, arterial oxygen tension; PaCO2, arterial CO2 tension; SaO2, arterial oxygen
saturation; Hgb, hemoglobin concentration; NOx, nitrite/nitrate concentration.
*p < 0.05 compared with baseline.
Table 2 | Venous concentrations of catecholamines and endothelial
markers before and after hypobaric hypoxia.
Baseline Recovery
Adrenaline (pg/ml) 84 (38–129) 57 (31–82)
Noradrenaline (pg/ml) 199 (117–280) 234 (134–334)
Syndecan-1 (ng/ml) 22 (17–27) 25 (19–30)*
PC (%) 76 (70–83) 81 (74–88)*
sTM (ng/ml) 6.0 (5.2–6.8) 6.1 (5.3–6.9)
tPA (ng/ml) 3.1 (1.5–4.7) 3.3 (1.4–5.3)
PAI-1 (ng/ml) 5.7 (0.3–11.2) 5.5 (−0.6–11.6)
sCD40L (pg/ml) 41 (13–68) 33 (24–42)
hcDNA (%) 2.6 (2.0–3.2) 2.6 (2.2–2.9)
Data are presented as means with 95% confidence limits. n = 11. PC, protein
C; sTM, soluble thrombomodulin; tPA, tissue plasminogen activators; PAI-
1, plasminogen activator inhibitor 1; sCD40L, soluble CD40 ligand; hcDNA,
histone-complexed DNA fragments. *p < 0.02 compared with baseline.
Measurements with the EndoPAT device could not be obtained
in one subject during baseline. Unexpected, the fingertip plethys-
mograph of the EndoPAT device failed to produce readable
tonometry (pulse-signal amplitude) in 5/12 subjects during
hypoxia. These subjects were the most affected by the decompres-
sion and presented with peripheral vasoconstriction. EndoPAT
RHI fell from 1.80 (1.52–2.07, n = 11) at baseline to 1.62 (1.28–
1.96) during hypoxia (n = 7; p = 0.11) but in the period of
post-hypoxia increased significantly to 2.43 (1.99–2.86, n = 12)
(Figure 1). At baseline 5/11 of the subjects had a RHI below
1.67 which is denoted as abnormal by the manufacturer of the
EndoPAT device. During hypoxia 4/7 of the subjects had RHI val-
ues below 1.67; after hypoxia only 1/12 had a RHI below 1.67. RHI
values at baseline and recovery did not correlate with correspond-
ing values of syndecan-1, protein C, or nitrite/nitrate. Nor did
RHI during hypoxia correlate with nitrite/nitrate values during
hypoxia. Nitrite/nitrate did not correlate with neither syndecan-1
or protein C. No trend was observed regarding degree of degrada-
tion of endothelial glycocalyx and reactive hyperemia in relation
to exposure time to hypobaric conditions.
DISCUSSION
The current study suggests that acute, short-term hypobaric
hypoxia in humans is associated with minor degradation of
the endothelium glycocalyx as reflected by the small increase in
syndecan-1. Increased plasma concentrations of protein C indi-
cate that acute hypobaric hypoxia induced some degree of cellular
damage. At the same time, a decrease in venous concentra-
tion of nitrite/nitrate was observed. RHI after hypoxic exposure
rebounded to higher than baseline levels. The present results are
in line with previous studies in isolated, perfused hearts of guinea
pigs (Annecke et al., 2011; Becker et al., 2011), and of rats (Ward
and Donelly, 1993) showing that hypoxia initiates degradation of
the coronary endothelial glycocalyx.
Acute hypoxia has often been shown to impair endothe-
lial function. Earlier studies showed an increased transcapillary
escape rate of albumin after 3.5 h and 2 days at 4500m (Parving,
1972; Hansen et al., 1994). Berger et al. (2005) have shown that
FIGURE 1 | EndoPAT reactive hyperemia index (RHI) at baseline
(n = 11), hypoxia (4500m for 2–4h, n = 7), and recovery (n = 12). Data
are presented as means with 95% confidence intervals. ∗p = 0.008
compared with baseline.
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the endothelium dependent vasodilator responsiveness of fore-
arm resistance vessels was blunted by acute normobaric hypoxia
in subjects susceptible to HAPE but not in HAPE resistant sub-
jects. Exhaled nitric oxide and pulmonary nitric oxide bioavail-
ability is reduced in HAPE susceptible subjects (Busch et al.,
2001; Swenson et al., 2002; Bailey et al., 2010). The present
hypoxia induced decrease in systemic venous concentration of
nitrite/nitrate is in accordance with previous studies (Bailey et al.,
2010; Beall et al., 2012). However, this is associated with an
increase in arterial nitrosoproteins and nitric oxide in red blood
cells (Bailey et al., 2010). The nitric oxide pathways in hypoxia
may both involve down-regulation of endothelial nitric oxide
synthase (Beall et al., 2012), and up-regulation of nitric oxide
formation from nitrite (Lundberg et al., 2008; David Ho et al.,
2012), but exactly how these interactions are related to the RHI
signal remains unknown. Interestingly, although hypoxia tended
to reduce RHI, it increased above baseline levels in the post-
hypoxia period, suggesting a beneficial role of hypoxia and its
reversal on endothelial integrity. It could be speculated that this
response, in part, may be involved in the beneficial effect of
hypoxic “conditioning” (Przyklenk, 2013; Thielmann et al., 2013).
Increased levels of catecholamines, syndecan-1 and soluble
thrombomodulin in patients with severe trauma, acute myocar-
dial infarction and sepsis are associated with increased mortality
(Johansson et al., 2011, 2012, 2013; Ostrowski et al., 2013a,b). In
the present study, short-term hypobaric hypoxia did not induce
significant increases in circulating catecholamines indicating that
an effect on the endothelium from symphathetic outflow was
negligible. In agreement with this, only modest increases in
syndecan-1 was observed and, furthermore, no change in solu-
ble thrombomodulin levels was found, indicating that no major
damage on the endothelial cells was inflicted. We have previously
reported that experimental endotoxemia in healthy volunteers
receiving a 4-h 0.5 ng/kg/h infusion of E. coli lipopolysaccharide
did not result in significant changes of circulating levels of cat-
echolamines, syndecan-1 or soluble thrombomodulin contrary
to patients with sepsis (Ostrowski et al., 2013a). Together with
the RHI results, this suggests that the hypoxia model used in
the present study resulted in a stronger endothelial impact than
the LPS model, albeit much weaker than in patients with sepsis.
The current level of hypoxia with an arterial oxygen saturation
around 80% is often observed following poisoning with cyanide
or carbonmonoxide in smoke inhalation injuries, and in the acute
course of several clinical syndromes, i.e., sepsis, trauma, pul-
monary thromboembolism and myocardial infarction. We found
increased levels of syndecan-1 indicating shedding of the glyco-
calyx which has been associated with poor outcome in trauma
patients (Johansson et al., 2011, 2012), whereas RHI increased as
a measure of improved endothelial functionality. The significance
of these findings requires further investigation.
We used a non-invasive EndoPat 2000 device for evaluation of
peripheral endothelial function by peripheral arterial tonometry
(PAT) (Hamburg and Benjamin, 2009; Patvardhan et al., 2010;
Hedetoft and Olsen, 2014). The method is based on amplitude
tonometry in the finger tip and provides easy and standardized
measurements of a RHI value following a 5-min upper arm occlu-
sion. A study in healthy individuals indicated that RHI, in part,
depends on flow-mediated release of nitric oxide (Nohria et al.,
2006). RHI is decreased in the presence of cardiovascular risk
factors (Bonetti et al., 2004; Hamburg et al., 2008, 2011), and
measurements of RHI may be used to predict risk of adverse car-
diovascular events after surgery (Gokce et al., 2002) and acute
coronary syndrome (Rubinshtein et al., 2010). Although pat-
terns of abnormalities measured by PAT follow the same trend
as that measured by brachial artery ultrasound in response to
flow-mediated vasodilatation (Kuvin et al., 2003), it has become
clear that the methods are not interchangeable (Lind et al., 2005;
Dhingsa et al., 2008; Hamburg et al., 2011). Endothelial function
in the brachial conduit artery and the smaller resistance vessels
in the finger are governed by different mechanisms, and the two
methods provide distinct information about endothelial function
(Lind et al., 2005; Dhingsa et al., 2008; Hamburg et al., 2011).
Nonetheless, the use of PAT may provide new ways to study the
interaction between hypoxia and peripheral flow dynamics.
LIMITATIONS
The time course in hypoxia plays an important role. Whereas
short-term hypoxia may result in vasoconstriction in pulmonary
and renal vessels and vasodilation in skeletal muscle, alterations in
glycocalyx may require longer time (Pries et al., 2000; Vink et al.,
2000; Nieuwdorp et al., 2006; Chappell et al., 2010; Johansson
et al., 2011; Ostrowski et al., 2013a,b). Thus, the present use of
only 2–4 h of hypoxiamay have been too short to reveal the poten-
tial effect on the glycocalyx. In addition, the failure of obtaining
fingertip plethysmographic signals with the EndoPAT device dur-
ing hypoxia unfortunately weakened the study. Thus, the study
would have benefited from inclusion of other measurements like
flow-mediated vasodilatation in the brachial artery and nitric
oxide bioavailability in red blood cells and exhaled air. Moreover,
assessment of biochemical markers of glycocalyx degradation
are indirect methods that are not comparable to direct inves-
tigation of the glycocalyx by electron-microscopy or confocal
microscopy.
CONCLUDING REMARKS
The increase in syndecan-1 and protein C suggests that acute
hypobaric hypoxia produces minor degree of glycocalyx degrada-
tion and overall cellular damage. After hypoxia RHI rebounded
to higher than baseline levels suggesting improved endothelial
functionality.
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